

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to gravity (GO:0009629) | 6.38657013 |
| 2 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.44147848 |
| 3 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.44147848 |
| 4 | adenosine metabolic process (GO:0046085) | 5.38102019 |
| 5 | platelet dense granule organization (GO:0060155) | 5.33359792 |
| 6 | regulation of memory T cell differentiation (GO:0043380) | 5.17480716 |
| 7 | regulation of plasminogen activation (GO:0010755) | 5.11873008 |
| 8 | muscle atrophy (GO:0014889) | 5.05771208 |
| 9 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.93455034 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.90575670 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.90575670 |
| 12 | negative regulation of Ras GTPase activity (GO:0034261) | 4.88128047 |
| 13 | homocysteine metabolic process (GO:0050667) | 4.86546766 |
| 14 | artery smooth muscle contraction (GO:0014824) | 4.74422357 |
| 15 | white fat cell differentiation (GO:0050872) | 4.74126370 |
| 16 | adult feeding behavior (GO:0008343) | 4.71460284 |
| 17 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.69989260 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.51099056 |
| 19 | adaptation of signaling pathway (GO:0023058) | 4.50990088 |
| 20 | striated muscle atrophy (GO:0014891) | 4.43656596 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.34195820 |
| 22 | skeletal muscle adaptation (GO:0043501) | 4.31185683 |
| 23 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.28265941 |
| 24 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.18251722 |
| 25 | cysteine metabolic process (GO:0006534) | 4.07843416 |
| 26 | purine nucleotide salvage (GO:0032261) | 4.07386991 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.06197425 |
| 28 | regulation of activation of Janus kinase activity (GO:0010533) | 3.99998072 |
| 29 | tonic smooth muscle contraction (GO:0014820) | 3.98466773 |
| 30 | desmosome organization (GO:0002934) | 3.97155088 |
| 31 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.92409492 |
| 32 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.84312575 |
| 33 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.83797001 |
| 34 | regulation of sequestering of triglyceride (GO:0010889) | 3.80627009 |
| 35 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.69445698 |
| 36 | negative regulation of interleukin-1 production (GO:0032692) | 3.60658343 |
| 37 | microtubule nucleation (GO:0007020) | 3.55463594 |
| 38 | positive regulation of glycolytic process (GO:0045821) | 3.53256672 |
| 39 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.43964209 |
| 40 | response to muscle activity (GO:0014850) | 3.43597251 |
| 41 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.40656151 |
| 42 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.29511997 |
| 43 | skeletal muscle tissue regeneration (GO:0043403) | 3.29428589 |
| 44 | negative regulation of acute inflammatory response (GO:0002674) | 3.28537431 |
| 45 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.26433404 |
| 46 | T-helper cell differentiation (GO:0042093) | 3.25209506 |
| 47 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.25209506 |
| 48 | negative regulation of lipid storage (GO:0010888) | 3.23066698 |
| 49 | hair cycle (GO:0042633) | 3.21362115 |
| 50 | molting cycle (GO:0042303) | 3.21362115 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21064424 |
| 52 | phenylpropanoid metabolic process (GO:0009698) | 3.20792359 |
| 53 | endocrine pancreas development (GO:0031018) | 3.17990502 |
| 54 | response to interleukin-15 (GO:0070672) | 3.13546533 |
| 55 | primary amino compound metabolic process (GO:1901160) | 3.09013640 |
| 56 | kynurenine metabolic process (GO:0070189) | 3.08370798 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.03016794 |
| 58 | inner ear receptor cell development (GO:0060119) | 3.02789507 |
| 59 | vascular smooth muscle contraction (GO:0014829) | 2.99242379 |
| 60 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.98823892 |
| 61 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.96153234 |
| 62 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96148173 |
| 63 | regulation of germinal center formation (GO:0002634) | 2.93192577 |
| 64 | response to lipoprotein particle (GO:0055094) | 2.93038198 |
| 65 | protein-chromophore linkage (GO:0018298) | 2.91619181 |
| 66 | positive regulation of histone acetylation (GO:0035066) | 2.90863833 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 2.90645854 |
| 68 | energy homeostasis (GO:0097009) | 2.89740869 |
| 69 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.87576503 |
| 70 | cytidine deamination (GO:0009972) | 2.82796728 |
| 71 | cytidine metabolic process (GO:0046087) | 2.82796728 |
| 72 | cytidine catabolic process (GO:0006216) | 2.82796728 |
| 73 | organic cation transport (GO:0015695) | 2.82248489 |
| 74 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.81701282 |
| 75 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80998618 |
| 76 | regulation of gonadotropin secretion (GO:0032276) | 2.80449810 |
| 77 | galactose metabolic process (GO:0006012) | 2.80253706 |
| 78 | galactose catabolic process (GO:0019388) | 2.77003749 |
| 79 | T cell differentiation involved in immune response (GO:0002292) | 2.76791514 |
| 80 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.76791514 |
| 81 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.76791514 |
| 82 | inositol phosphate-mediated signaling (GO:0048016) | 2.72779916 |
| 83 | ceramide catabolic process (GO:0046514) | 2.72745428 |
| 84 | negative regulation of muscle hypertrophy (GO:0014741) | 2.68529181 |
| 85 | mitochondrial RNA metabolic process (GO:0000959) | 2.67289039 |
| 86 | nucleoside transmembrane transport (GO:1901642) | 2.61786588 |
| 87 | neutrophil activation (GO:0042119) | 2.59384869 |
| 88 | regulation of tight junction assembly (GO:2000810) | 2.59303465 |
| 89 | positive regulation of protein acetylation (GO:1901985) | 2.58173722 |
| 90 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 2.58173722 |
| 91 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.57825651 |
| 92 | reciprocal DNA recombination (GO:0035825) | 2.57284074 |
| 93 | reciprocal meiotic recombination (GO:0007131) | 2.57284074 |
| 94 | positive regulation of heat generation (GO:0031652) | 2.57094879 |
| 95 | COPII vesicle coating (GO:0048208) | 2.56496956 |
| 96 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.56291024 |
| 97 | cellular response to leptin stimulus (GO:0044320) | 2.53847810 |
| 98 | cellular ketone body metabolic process (GO:0046950) | 2.52079844 |
| 99 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.51728122 |
| 100 | positive regulation of cell fate commitment (GO:0010455) | 2.49597619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.44884891 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.61029207 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 4.55995183 |
| 4 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.08378088 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76897830 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.55297462 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38616165 |
| 8 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.36749981 |
| 9 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.25322000 |
| 10 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.23112427 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22172321 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09449972 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00279880 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88362214 |
| 15 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.85458885 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84625380 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.84397901 |
| 18 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.75334016 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73358028 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68972179 |
| 21 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.67900348 |
| 22 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.65313585 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59747678 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56068535 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54965579 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53683194 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.52684747 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47586575 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47304389 |
| 30 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45913512 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44156468 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43383233 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39288789 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35332702 |
| 35 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.32060022 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29956813 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29767477 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29426090 |
| 39 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26408280 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24101892 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22614212 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22132685 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20406032 |
| 44 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19999664 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18502653 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18353385 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17978144 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13782819 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13202511 |
| 50 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12874478 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12781736 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12434808 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11437491 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11363490 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11363490 |
| 56 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10655199 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10532516 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09131461 |
| 59 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07322335 |
| 60 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.06887127 |
| 61 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.06307906 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05625663 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04303783 |
| 64 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03805527 |
| 65 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03805527 |
| 66 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03482644 |
| 67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03242252 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03242252 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02676525 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02670318 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02296512 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02135195 |
| 73 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00861750 |
| 74 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99863574 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99226150 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98475314 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98158389 |
| 78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97144056 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97125189 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95516018 |
| 81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95504998 |
| 82 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94380250 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93671120 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93644731 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92767903 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91779020 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91497610 |
| 88 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91188269 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90049466 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89291728 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89155019 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89134724 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88741361 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88133964 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86867839 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85934730 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 0.85797094 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84751714 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84199737 |
| 100 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.83320216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.69688277 |
| 2 | MP0005670_abnormal_white_adipose | 4.49341817 |
| 3 | MP0000013_abnormal_adipose_tissue | 3.40425888 |
| 4 | MP0008995_early_reproductive_senescence | 2.73426695 |
| 5 | MP0002736_abnormal_nociception_after | 2.69038696 |
| 6 | MP0005360_urolithiasis | 2.44995097 |
| 7 | MP0004885_abnormal_endolymph | 2.44061434 |
| 8 | MP0003787_abnormal_imprinting | 2.39779805 |
| 9 | MP0005646_abnormal_pituitary_gland | 2.36542745 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.23389772 |
| 11 | MP0008872_abnormal_physiological_respon | 2.22276781 |
| 12 | MP0003011_delayed_dark_adaptation | 2.09038641 |
| 13 | MP0004147_increased_porphyrin_level | 2.02982827 |
| 14 | MP0003195_calcinosis | 1.97977401 |
| 15 | MP0002822_catalepsy | 1.97397569 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 1.88987249 |
| 17 | MP0001968_abnormal_touch/_nociception | 1.88195721 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.82670082 |
| 19 | MP0004043_abnormal_pH_regulation | 1.80731658 |
| 20 | MP0001661_extended_life_span | 1.80138156 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.68382951 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.61278642 |
| 23 | MP0000516_abnormal_urinary_system | 1.59203085 |
| 24 | MP0005367_renal/urinary_system_phenotyp | 1.59203085 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.53358547 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.49713543 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.48269610 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.48170747 |
| 29 | MP0002938_white_spotting | 1.47686615 |
| 30 | MP0000427_abnormal_hair_cycle | 1.46451470 |
| 31 | MP0005332_abnormal_amino_acid | 1.45595599 |
| 32 | MP0005253_abnormal_eye_physiology | 1.44092745 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.43014548 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.42184093 |
| 35 | MP0001270_distended_abdomen | 1.41487242 |
| 36 | MP0002254_reproductive_system_inflammat | 1.40526693 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.39550909 |
| 38 | MP0003646_muscle_fatigue | 1.36180442 |
| 39 | MP0002009_preneoplasia | 1.34139318 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.33742049 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.32388817 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.27377968 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.27177204 |
| 44 | MP0003252_abnormal_bile_duct | 1.25694909 |
| 45 | MP0001944_abnormal_pancreas_morphology | 1.23103793 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.22482007 |
| 47 | MP0000383_abnormal_hair_follicle | 1.21912449 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.20276688 |
| 49 | MP0000747_muscle_weakness | 1.18773112 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.17936534 |
| 51 | MP0003638_abnormal_response/metabolism_ | 1.15714921 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.15066533 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.14164627 |
| 54 | MP0005448_abnormal_energy_balance | 1.13860728 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 1.13409389 |
| 56 | MP0002933_joint_inflammation | 1.12635023 |
| 57 | MP0001851_eye_inflammation | 1.12267685 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.11892181 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 1.11518558 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.10902740 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.09728931 |
| 62 | MP0003786_premature_aging | 1.08861453 |
| 63 | MP0001765_abnormal_ion_homeostasis | 1.07613091 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.05826780 |
| 65 | MP0003878_abnormal_ear_physiology | 1.05826780 |
| 66 | MP0001486_abnormal_startle_reflex | 1.05725597 |
| 67 | MP0002971_abnormal_brown_adipose | 1.02881636 |
| 68 | MP0003436_decreased_susceptibility_to | 1.02831838 |
| 69 | MP0004133_heterotaxia | 1.01713939 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 1.00411177 |
| 71 | MP0004130_abnormal_muscle_cell | 0.99698363 |
| 72 | MP0002269_muscular_atrophy | 0.98470835 |
| 73 | MP0003045_fibrosis | 0.97964966 |
| 74 | MP0005535_abnormal_body_temperature | 0.97893896 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.95989908 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.92997354 |
| 77 | MP0001502_abnormal_circadian_rhythm | 0.90841228 |
| 78 | MP0005671_abnormal_response_to | 0.88274467 |
| 79 | MP0000371_diluted_coat_color | 0.86684016 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.86083181 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.84935876 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.84161162 |
| 83 | MP0008004_abnormal_stomach_pH | 0.84091434 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.80496678 |
| 85 | MP0004924_abnormal_behavior | 0.80496678 |
| 86 | MP0009764_decreased_sensitivity_to | 0.80192852 |
| 87 | MP0003953_abnormal_hormone_level | 0.79824314 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.79356583 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.78958076 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 0.78423525 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.77938535 |
| 92 | MP0009115_abnormal_fat_cell | 0.77573253 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.76388148 |
| 94 | MP0001919_abnormal_reproductive_system | 0.76222934 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.76160236 |
| 96 | MP0005334_abnormal_fat_pad | 0.72722930 |
| 97 | MP0005164_abnormal_response_to | 0.70978794 |
| 98 | MP0001529_abnormal_vocalization | 0.69450086 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.68976516 |
| 100 | MP0000749_muscle_degeneration | 0.68811627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 5.68860829 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 5.68860829 |
| 3 | Hyperalaninemia (HP:0003348) | 5.68860829 |
| 4 | Congenital sensorineural hearing impairment (HP:0008527) | 4.41172817 |
| 5 | Myositis (HP:0100614) | 4.19201090 |
| 6 | Optic neuritis (HP:0100653) | 3.97906799 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.97906799 |
| 8 | White forelock (HP:0002211) | 3.80667455 |
| 9 | Constricted visual fields (HP:0001133) | 3.69839709 |
| 10 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.67715146 |
| 11 | Orchitis (HP:0100796) | 3.59131310 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.51080486 |
| 13 | Anorexia (HP:0002039) | 3.50528754 |
| 14 | Myopathic facies (HP:0002058) | 3.36689313 |
| 15 | Action tremor (HP:0002345) | 3.33843649 |
| 16 | Hyperglycemia (HP:0003074) | 3.30174971 |
| 17 | Patchy hypopigmentation of hair (HP:0011365) | 3.26452252 |
| 18 | Esophageal varix (HP:0002040) | 3.19251896 |
| 19 | Short tibia (HP:0005736) | 3.13215966 |
| 20 | Delayed CNS myelination (HP:0002188) | 3.09549687 |
| 21 | Pulmonary embolism (HP:0002204) | 3.06540569 |
| 22 | Abnormality of homocysteine metabolism (HP:0010919) | 3.03898917 |
| 23 | Homocystinuria (HP:0002156) | 3.03898917 |
| 24 | Myocardial infarction (HP:0001658) | 2.97280050 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 2.91885955 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.90434332 |
| 27 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.86118998 |
| 28 | Intestinal atresia (HP:0011100) | 2.72601276 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 2.71520799 |
| 30 | Thyroiditis (HP:0100646) | 2.70238331 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 2.54290333 |
| 32 | Stomatitis (HP:0010280) | 2.46800796 |
| 33 | Chronic hepatic failure (HP:0100626) | 2.46782475 |
| 34 | Poor speech (HP:0002465) | 2.45339479 |
| 35 | Hematochezia (HP:0002573) | 2.44007510 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.42922464 |
| 37 | Oligomenorrhea (HP:0000876) | 2.41847197 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.41472320 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39319347 |
| 40 | Hemoptysis (HP:0002105) | 2.38206914 |
| 41 | Arterial thrombosis (HP:0004420) | 2.31958142 |
| 42 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31269402 |
| 43 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31269402 |
| 44 | Single umbilical artery (HP:0001195) | 2.31269402 |
| 45 | Fibular hypoplasia (HP:0003038) | 2.30829074 |
| 46 | Ketoacidosis (HP:0001993) | 2.29282798 |
| 47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.28397074 |
| 48 | Abnormal pupillary function (HP:0007686) | 2.27167200 |
| 49 | Abolished electroretinogram (ERG) (HP:0000550) | 2.25304945 |
| 50 | Brittle hair (HP:0002299) | 2.24052353 |
| 51 | Neoplasm of the heart (HP:0100544) | 2.23351846 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.18515931 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.16725022 |
| 54 | Pendular nystagmus (HP:0012043) | 2.16034516 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.08828701 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08654533 |
| 57 | Maternal diabetes (HP:0009800) | 2.08216691 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.06852972 |
| 59 | Anteriorly placed anus (HP:0001545) | 2.06271229 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05277553 |
| 61 | Granulocytopenia (HP:0001913) | 2.01591303 |
| 62 | Tubulointerstitial nephritis (HP:0001970) | 2.00046449 |
| 63 | Hyperphosphatemia (HP:0002905) | 1.98907509 |
| 64 | Agitation (HP:0000713) | 1.98424201 |
| 65 | Metaphyseal dysplasia (HP:0100255) | 1.97452708 |
| 66 | Chorioretinal atrophy (HP:0000533) | 1.96711204 |
| 67 | Heterochromia iridis (HP:0001100) | 1.95479852 |
| 68 | Gingival bleeding (HP:0000225) | 1.93962620 |
| 69 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.91273986 |
| 70 | Congenital stationary night blindness (HP:0007642) | 1.90902653 |
| 71 | Abnormality of the parietal bone (HP:0002696) | 1.89962491 |
| 72 | Pancreatic fibrosis (HP:0100732) | 1.87173256 |
| 73 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.86867814 |
| 74 | True hermaphroditism (HP:0010459) | 1.84027754 |
| 75 | Pancreatitis (HP:0001733) | 1.83046272 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 1.82447791 |
| 77 | Pancreatic cysts (HP:0001737) | 1.81777471 |
| 78 | Epidermoid cyst (HP:0200040) | 1.81348627 |
| 79 | T lymphocytopenia (HP:0005403) | 1.80654784 |
| 80 | Palpebral edema (HP:0100540) | 1.77510392 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 1.77134362 |
| 82 | Prolonged QT interval (HP:0001657) | 1.73804919 |
| 83 | Portal hypertension (HP:0001409) | 1.73535004 |
| 84 | Episodic fever (HP:0001954) | 1.73371840 |
| 85 | Severe visual impairment (HP:0001141) | 1.71558857 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 1.71196420 |
| 87 | Nemaline bodies (HP:0003798) | 1.70200473 |
| 88 | Conical tooth (HP:0000698) | 1.70110414 |
| 89 | Metabolic acidosis (HP:0001942) | 1.69355771 |
| 90 | Petechiae (HP:0000967) | 1.68049927 |
| 91 | Hyperphosphaturia (HP:0003109) | 1.67019628 |
| 92 | Pustule (HP:0200039) | 1.66355596 |
| 93 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.66275988 |
| 94 | Vascular calcification (HP:0004934) | 1.65739139 |
| 95 | Albinism (HP:0001022) | 1.63954868 |
| 96 | Disproportionate short-trunk short stature (HP:0003521) | 1.63383207 |
| 97 | Chronic otitis media (HP:0000389) | 1.62809773 |
| 98 | Hypolipoproteinemia (HP:0010981) | 1.62315741 |
| 99 | Abnormality of lateral ventricle (HP:0030047) | 1.61798306 |
| 100 | Hyperkalemia (HP:0002153) | 1.61444834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 3.50222286 |
| 2 | MAP4K2 | 3.38823124 |
| 3 | FRK | 3.17879967 |
| 4 | MAP2K3 | 3.17538588 |
| 5 | TLK1 | 2.59141024 |
| 6 | JAK3 | 2.56056216 |
| 7 | TAOK3 | 2.49019162 |
| 8 | MAP3K14 | 2.42184132 |
| 9 | TXK | 2.39691516 |
| 10 | ACVR1B | 2.18295384 |
| 11 | NUAK1 | 2.16621109 |
| 12 | PHKG2 | 2.15666502 |
| 13 | PHKG1 | 2.15666502 |
| 14 | ZAK | 1.93556210 |
| 15 | FES | 1.85184250 |
| 16 | IRAK1 | 1.84591657 |
| 17 | GRK6 | 1.82810075 |
| 18 | IKBKE | 1.82036759 |
| 19 | INSRR | 1.81597891 |
| 20 | BMPR1B | 1.56319298 |
| 21 | LATS1 | 1.51129293 |
| 22 | DAPK2 | 1.50882624 |
| 23 | IKBKB | 1.45517347 |
| 24 | OBSCN | 1.42918417 |
| 25 | SGK223 | 1.38380368 |
| 26 | SGK494 | 1.38380368 |
| 27 | GRK1 | 1.35645726 |
| 28 | SGK2 | 1.32834521 |
| 29 | MET | 1.31796851 |
| 30 | MAP2K2 | 1.23699839 |
| 31 | FGFR2 | 1.21583437 |
| 32 | MAP4K1 | 1.21425417 |
| 33 | FGR | 1.20651912 |
| 34 | JAK1 | 1.16975885 |
| 35 | TBK1 | 1.13488332 |
| 36 | MAP3K9 | 1.06955806 |
| 37 | PAK3 | 1.02261449 |
| 38 | STK3 | 0.99582643 |
| 39 | NEK6 | 0.98774613 |
| 40 | EPHA3 | 0.95252246 |
| 41 | MAP2K1 | 0.94216995 |
| 42 | TIE1 | 0.93277009 |
| 43 | PTK2B | 0.92634443 |
| 44 | SGK3 | 0.92338418 |
| 45 | KDR | 0.91795850 |
| 46 | FER | 0.90958870 |
| 47 | RIPK4 | 0.89920570 |
| 48 | MATK | 0.89658440 |
| 49 | CDK9 | 0.84166468 |
| 50 | CHUK | 0.79695506 |
| 51 | MST4 | 0.79183067 |
| 52 | NTRK2 | 0.79145007 |
| 53 | PINK1 | 0.77576177 |
| 54 | MAP2K6 | 0.77373738 |
| 55 | PRKCE | 0.74449538 |
| 56 | IRAK4 | 0.74404990 |
| 57 | WNK1 | 0.72863213 |
| 58 | ADRBK2 | 0.72075912 |
| 59 | MAP3K1 | 0.71111864 |
| 60 | FGFR3 | 0.70225384 |
| 61 | PIK3CA | 0.69778937 |
| 62 | MKNK2 | 0.68434066 |
| 63 | TNK2 | 0.64051521 |
| 64 | MAPK7 | 0.62710390 |
| 65 | ADRBK1 | 0.62530272 |
| 66 | EPHB1 | 0.62356075 |
| 67 | NLK | 0.62226719 |
| 68 | MAPK13 | 0.61539955 |
| 69 | SYK | 0.57404640 |
| 70 | OXSR1 | 0.56782869 |
| 71 | SIK3 | 0.56469610 |
| 72 | TNIK | 0.56434928 |
| 73 | YES1 | 0.54435435 |
| 74 | ERN1 | 0.53603193 |
| 75 | EIF2AK2 | 0.52045925 |
| 76 | SGK1 | 0.51375228 |
| 77 | SIK1 | 0.50864192 |
| 78 | AURKA | 0.50800677 |
| 79 | IRAK2 | 0.48236572 |
| 80 | CSNK1A1 | 0.46881686 |
| 81 | HCK | 0.44239224 |
| 82 | TEC | 0.43645187 |
| 83 | CAMK1 | 0.42541859 |
| 84 | PRKG2 | 0.40448978 |
| 85 | LYN | 0.37846270 |
| 86 | PRKCA | 0.35772055 |
| 87 | PRKAA2 | 0.35732155 |
| 88 | CSF1R | 0.35379058 |
| 89 | LCK | 0.34648958 |
| 90 | JAK2 | 0.34319789 |
| 91 | PIM1 | 0.32832942 |
| 92 | STK38 | 0.32421830 |
| 93 | PKN1 | 0.31590953 |
| 94 | CSNK1D | 0.31539376 |
| 95 | KIT | 0.31376910 |
| 96 | RPS6KA1 | 0.31330736 |
| 97 | STK4 | 0.31162981 |
| 98 | MARK3 | 0.30988579 |
| 99 | CCNB1 | 0.29911287 |
| 100 | EGFR | 0.29822495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.67809673 |
| 2 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.26456139 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.25839672 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.21301521 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.35486318 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.21997500 |
| 7 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.14743987 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.09902809 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.04524421 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86988358 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.86042190 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66053200 |
| 13 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.61977118 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.57059709 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46655536 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45619137 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41903659 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40958189 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38836576 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38200636 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37998176 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.33812987 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33653720 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.32865787 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.30495257 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26852162 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25128759 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20518051 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20484226 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15012921 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.14223239 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13883870 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12703364 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12514164 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11948532 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10747034 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.09159034 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07609182 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07362157 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03533852 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03152668 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02036556 |
| 43 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01570833 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01550518 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.01320789 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00861233 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.00424587 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00319700 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96450634 |
| 50 | Alcoholism_Homo sapiens_hsa05034 | 0.92790539 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92057232 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91438193 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90967776 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90725545 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88072817 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87346265 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86988623 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83193479 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82920952 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82039042 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81268552 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80484851 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75699607 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71981865 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.69775162 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69155913 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.68339681 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68261272 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67425957 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66725434 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66538005 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.66224412 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64461776 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62907767 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62561175 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62399947 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61475574 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61125241 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60716862 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56628489 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52729079 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51500758 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49590198 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48100376 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45405116 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43925527 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42242941 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.40691895 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.39154993 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.37607303 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37400217 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36243156 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33379699 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.32472060 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30619391 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29276863 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28153315 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27091131 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26881548 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26504628 |

